HIND
Vyome·NASDAQ
--
--(--)
--
--(--)
HIND fundamentals
Vyome (HIND) Revenue Breakdown: Q3 2025 Business & Regional Performance
Vyome (HIND) reported total revenue of 34.63K USD in Q3 2025, with its core business segment Pharmaceutical contributing 100.00%. Regionally, United States remained the largest market, accounting for 87.92% of total revenue. Explore Vyome's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
Vyome (HIND) reported total revenue of 34.63K USD in Q3 2025, with its core business segment Pharmaceutical contributing 100.00%. Regionally, United States remained the largest market, accounting for 87.92% of total revenue. Explore Vyome's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
What factors drove the changes in Vyome's revenue and profit?What is the market's earnings forecast for Vyome next quarter?What is the revenue and EPS growth rate for Vyome year over year?What is Vyome's latest dividend and current dividend yield?What guidance did Vyome's management provide for the next earnings period?What were the key takeaways from Vyome’s earnings call?What were the key takeaways from Vyome's earnings call?Did Vyome beat or miss consensus estimates last quarter?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
